James W. Mccollum - Mar 21, 2024 Form 3 Insider Report for LENZ Therapeutics, Inc. (LENZ)

Role
Director
Signature
/s/ Evert Schimmelpennink, as Attorney-in-Fact
Stock symbol
LENZ
Transactions as of
Mar 21, 2024
Transactions value $
$0
Form type
3
Date filed
3/25/2024, 08:26 PM
Next filing
May 14, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney